Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alseres Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Pikeaholic who wrote (582)	5/5/1998 3:02:00 PM
From: SR/WA	Read Replies (1) \| Respond to of 975

Never have been able to picked a "bottom" yet so I'm gonna watch & wait awhile longer. Ken

To: Pikeaholic who wrote (582)	5/5/1998 7:00:00 PM
From: ernie de la fuente	Read Replies (1) \| Respond to of 975

I hate to admit it but I bailed 2 minutes after posting the review of the CNBC interview. When I saw the drop to 7 in the first 10 minutes, I feared we would see much lower prices. I will re-enter, just not sure when. Just that fact that any of us are reading the thread means we are somewhat interested. You would have to be nuts not to at least position yourselves with some shares. If we are the first to hit human trials later this year and the results are even remotely positive, this is an easy 10 bagger. I think any prices under $5 would be tough to argue as a bad purchase in small amounts, no rent money but remember...... To be a millionaire, you need $10,000 and two 10 baggers....could this be one of them? For the next few weeks or months, we will probably see a drift downward with occassional spikes due to a news release or speculation. If we ink deals with supposed "big brothers", I doubt we will be able to buy for less than $10 at that point. Worth watching daily IMO. Will be very tough to predict the bottom(somewhere between $2-$5). Anyone want to take a tech analysts approach to a price? Good luck all!